Hiroyuki Mano

USPTO Granted Patents = 12 (Patent Applications = 3)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 4.6

ph-index = 5

Forward Citations = 56(Granted Patents)

Location History:

Tochigi, JP (2015)
Tokyo, JP (2008 - 2023)

Company Filing History:

The University of Tokyo

National Hospital Organization

patents

8. 1 out of 56

Japanese Foundation for Cancer Research

patents

9. 1 out of 9

Educational Foundation Jichi Medical University

patents

10. 1 out of 31

Jichi Medical University

patents

where one patent can have more than one assignee

Years Active: 2008-2023

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11542497 - Method for evaluating multiple different genes of interest (2023-01-03),

2. 10828377 - Method for determining presence or absence of suffering from malignant lymphoma or leukemia, and agent for treatment and/or prevention of leukemia (2020-11-10),

3. 9932589 - EML4-ALK fusion gene (2018-04-03),

4. 9109259 - Detection method for novel ROS1 fusions (2015-08-18),

5. 9029521 - EML4-ALK fusion gene (2015-05-12),

6. 9018230 - Identification, assessment, and therapy of cancers with innate or acquired resistance to ALK inhibitors (2015-04-28),

7. 8318702 - Di(arylamino)aryl compounds (2012-11-27),

8. 8197818 - EML4-ALK fusion gene (2012-06-12),

9. 7964710 - EML4-ALK fusion gene (2011-06-21),

10. 7728120 - EML4-ALK fusion gene (2010-06-01),

11. 7605131 - EML4-ALK fusion gene (2009-10-20),

12. 7335698 - Fluoropolymer containing ethylenically unsaturated groups, and curable resin compositions and antireflection coatings, made by using the same (2008-02-26),

Title: Hiroyuki Mano: Innovator in Genetic Evaluation and Cancer Treatment

Introduction

Hiroyuki Mano is a prominent inventor based in Tokyo, Japan, known for his significant contributions to the fields of genetics and oncology. With a total of 12 patents to his name, he has developed innovative methods that enhance the understanding and treatment of various genetic conditions and cancers.

Latest Patents

One of his latest patents is a method for evaluating multiple different genes of interest. This invention aims to provide a comprehensive approach to assess the function of various genes and their potential impact on drug sensitivity in subjects. The method involves integrating polynucleotides into host cell genomic DNA, culturing mixed host cells, and quantifying the polynucleotides to determine relative cell counts.

Another notable patent focuses on determining the presence or absence of malignant lymphoma or leukemia. This invention outlines a method for detecting specific genetic mutations associated with these diseases, allowing for early diagnosis and the development of targeted treatments. The patent also includes a pharmaceutical composition that utilizes a DUX4 inhibitor to treat or prevent these conditions.

Career Highlights

Hiroyuki Mano has worked with several reputable companies, including Astellas Pharma GmbH and Curegene K.K. His experience in these organizations has contributed to his expertise in pharmaceutical development and genetic research.

Collaborations

He has collaborated with notable professionals in his field, including Sadao Kuromitsu and Nobuaki Shindo. These partnerships have furthered his research and innovation efforts.

Conclusion

Hiroyuki Mano's work exemplifies the intersection of genetics and medicine, showcasing his commitment to advancing healthcare through innovative solutions. His patents reflect a deep understanding of genetic evaluation and cancer treatment, positioning him as a key figure in his field.

This text is generated by artificial intelligence and may not be accurate.